CD79A and COVID-19: Except higher NAb and NP- specific IgA and IgM (Supplementary Figure 5B), NP-, S-, RBD- specific IgG1 and NP- specific IgG3 subclass responses were higher in COVID-19 patients with comorbidity compared to patients without comorbidities (Figure 6D).